PeerJ,
Journal Year:
2025,
Volume and Issue:
13, P. e19046 - e19046
Published: March 24, 2025
Diabetic
peripheral
neuropathy
(DPN)
is
a
significant
complication
of
diabetes
with
limited
effective
therapeutic
options.
Sodium
alginate
(SA),
natural
polysaccharide
from
brown
algae,
has
demonstrated
health
benefits,
however,
whether
it
can
treat
streptozotocin
(STZ)-induced
DPN
remains
unclear.
The
present
experiment
aimed
to
test
the
preventive
role
SA
on
STZ-induced
in
rats
and
explored
possible
mechanisms.
rat
model
was
established
by
intraperitoneal
injection
single
dose
40
mg/kg
b.w.
STZ,
(200
b.w./day)
orally
administered
for
28
days
after
type
2
mellitus
(T2DM)
induction.
obtained
findings
revealed
that
STZ
significantly
increased
serum
levels
FBG,
HOMA-IR,
TC,
TG,
VLDL-C,
LDL-C,
while
decreased
insulin,
incretin
GLP-1,
HDL-C,
lipase
activity.
In
sciatic
nerves,
proinflammatory
cytokine
(IL-1β,
IL-6,
TNF-α),
caspase-3
(a
pro-apoptotic
protein),
markers
oxidative
stress
(MDA
NO),
AGEs.
parallel,
induced
decline
activities
enzymatic
antioxidants,
viz.
,
SOD,
CAT,
GPx,
non-enzymatic
GSH.
These
changes
were
accompanied
low
expression
miR-146a
nerves
rats.
Except
treatment
injected
improved
these
parameters
helped
rescue
neurological
morphology
nerve
fibers.
conclusion,
mitigated
experimental
DPN,
this
might
be
due
its
ability
suppress
hyperglycemic-hyperlipidemic
effects,
counteract
overactivation
inflammatory
molecules,
increase
expression,
modulate
dysregulation,
reduce
cell
apoptosis.
World Journal of Diabetes,
Journal Year:
2025,
Volume and Issue:
16(3)
Published: Jan. 20, 2025
BACKGROUND
The
risk
factors
and
prediction
models
for
diabetic
foot
(DF)
remain
incompletely
understood,
with
several
potential
still
requiring
in-depth
investigations.
AIM
To
identify
new-onset
DF
develop
a
robust
model
hospitalized
patients
type
2
diabetes.
METHODS
We
included
6301
diabetes
from
January
2016
to
December
2021.
A
univariate
Cox
least
absolute
shrinkage
selection
operator
analyses
were
applied
select
the
appropriate
predictors.
Nonlinear
associations
between
continuous
variables
of
explored
using
restricted
cubic
spline
functions.
was
further
employed
evaluate
impact
on
DF.
area
under
curve
(AUC)
measured
accuracy
model.
RESULTS
Seventy-five
inpatients
experienced
incidence
density
4.5/1000
person-years.
long
duration
diabetes,
lower
extremity
arterial
disease,
serum
albumin,
fasting
plasma
glucose
(FPG),
nephropathy
independently
associated
Among
these
factors,
albumin
concentration
inversely
DF,
hazard
ratio
(HR)
95%
confidence
interval
(CI)
0.91
(0.88-0.95)
(P
<
0.001).
Additionally,
U
-shaped
nonlinear
relationship
observed
FPG
level
After
adjusting
other
variables,
HRs
95%CI
4.4
mmol/L
≥
7.0
3.99
(1.55-10.25)
=
0.004)
3.12
(1.66-5.87)
0.001),
respectively,
which
greater
than
mid-range
(4.4-6.9
mmol/L).
AUC
predicting
over
3
years
0.797.
CONCLUSION
demonstrated
Serum
levels
negatively
nomogram
showed
good
discrimination
ability
duration,
FPG,
(Clinicaltrial.gov
NCT05519163).
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 21, 2025
Growing
evidence
suggests
that
hyperglycemia-related
abnormalities
in
Schwann
cells
play
a
pivotal
role
the
development
and
progression
of
diabetic
peripheral
neuropathy
(DPN).
Several
immortalized
cell
lines
have
been
established
our
laboratory
utilized
for
study
DPN;
IMS32
from
normal
ICR
mice,
1970C3
C57BL/6
IWARS1
IKARS1
wild-type
aldose
reductase-deficient
IFRS1
Fischer
344
rats.
These
retain
biological
features
display
high
proliferative
activities
enable
us
to
perform
molecular
biochemical
analyses.
In
addition,
these
exhibited
metabolic
alterations
under
exposure
diabetes-associated
conditions,
such
as
hyperglycemia,
dyslipidemia,
glycative
oxidative
stress
load.
Herein,
recent
studies
with
regarding
pathogenic
factors
DPN
(augmentation
polyol
other
collateral
glycolysis
pathways,
stress-induced
injury,
autophagic
proteostatic
disturbances,
etc.)
therapeutic
strategies
targeting
are
introduced.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(2), P. 228 - 228
Published: Feb. 7, 2025
Background:
Treatment
of
painful
diabetic
neuropathy
(PDN)
poses
several
challenges
due
to
the
limited
effectiveness,
high
incidence
side
effects,
and
potential
drug
interactions
oral
neuropathic
pain
medication.
Lacking
systemic
topical
phenytoin
cream
offers
a
promising
innovative
approach
addressing
unmet
needs
in
treatment.
In
this
retrospective
study
patients
with
PDN,
we
evaluated
analgesic
effect
response
tests
after
extended
use.
Methods:
We
collected
data
from
PDN
who,
prior
prolonged
use
10%
or
20%
cream,
either
had
an
open
test
(ORET),
single-blind
(SIBRET),
double-blind
(DOBRET)
placebo-controlled
between
November
2016
February
2023.
A
positive
ORET
was
defined
as
reduction
at
least
two
points
on
11-point
numerical
scale
(NRS)
within
30
min
application.
SIBRET
DOBRET
required
additional
1
NRS
point
treated
area
compared
placebo.
test,
sustained
proportion
experiencing
minimum
relief
30%
(MPR30:
moderate
relief)
50%
(MPR50:
considerable
cream.
also
assessed
correlation
relief.
Results:
identified
65
whom
31
(47.7%)
test.
The
median
3.0
(IQR
2.0-4.0).
Extended
(median
3.3
months,
IQR
1.5-12.1])
resulted
4.0
3.0-5.0);
26/31
(83.9%)
achieved
MPR30,
21/31
(67.7%)
MPR50
correlated
significantly
(τ
=
0.72,
p
<
0.0001).
Conclusions:
who
provided
significant
British Journal of Nursing,
Journal Year:
2025,
Volume and Issue:
34(4), P. S12 - S23
Published: Feb. 19, 2025
Diabetic
foot
disease
is
a
severe
complication
of
diabetes,
leading
to
significant
morbidity
and
lower
limb
amputations.
This
review
explores
the
pathophysiology
diabetic
disease,
highlighting
roles
peripheral
neuropathy,
arterial
immunosuppression
in
development
ulcers
infections.
Key
intrinsic
extrinsic
risk
factors,
including
long-standing
poor
glycaemic
control,
inappropriate
footwear
trauma
are
discussed.
The
importance
comprehensive
assessments
using
diagnostic
tools
such
as
Ipswich
Touch
Test
Doppler
studies
emphasised
for
early
detection
management.
Challenges
delays
referral
specialist
care,
limited
access
multidisciplinary
teams,
staffing
shortages
identified
critical
barriers
effective
care.
builds
upon
extant
literature
by
integrating
most
recent
evidence,
2023
guidelines
from
International
Working
Group
on
Foot.
It
emphasises
practical
application,
detailed
pathways
care
strategies,
offering
updated
insights
improve
clinical
outcomes
address
often
overlooked
aspects
within
inpatient
services.
Future
directions
encompass
advances
imaging,
telemedicine
patient
education,
which
may
further
optimise
preventive
therapeutic
strategies
disease.
Journal of Family Medicine and Primary Care,
Journal Year:
2025,
Volume and Issue:
14(2), P. 687 - 692
Published: Feb. 1, 2025
Among
type
2
diabetics
(T2D),
macrovascular
complication
lower
limb
Peripheral
Arterial
Disease
(PAD)
and
microvascular
Diabetic
Sensory
Neuropathy
(DPSN)
have
scarcely
studied
concordance
their
association
with
obesity.
Qualitative
general
body
fat
parameters
give
a
complete
picture
of
We
the
vibration
perception
threshold
(VPT)-based
DSPN
ankle
brachial
pressure
index
(ABPI))-based
PAD,
effect
obesity
on
them,
in
T2Ds.
A
cross-sectional
study
was
done
152
under-treatment
Bio-esthesiometer-based
VPT
from
sole
each
foot
VersaDop-based
ABPI
all
limbs
were
assessed.
Prevalence
(VPT
≥25)
PAD
(ABPI
≤0.9)
measured
compared
for
concomitance.
The
odds
ratio
used
testing
multiple
linear
regressions
accomplished
predictors
taking
P
value
<
0.05
as
statistically
significant.
T2Ds
had
mean
age
53
years,
duration
67
months,
48%
glycemic
control.
prevalence
abnormal
64%
23%,
respectively.
VPT-based
subgroups
do
not
defer
significantly
vice
versa.
Obesity
associated
only
(visceral
>
general).
Odd's
neuropathy
vasculopathy
insignificant
while
differences
significant
predictors.
having
23%
one-third
concomitance
but
lack
different
each.
Vasculopathy
obesity;
visceral
more
than
general;
suggesting
scope
its
rectification.
It
suggests
progression
these
complications,
despite
some
cross-talk
between
them.
IBRO Neuroscience Reports,
Journal Year:
2025,
Volume and Issue:
18, P. 512 - 519
Published: Feb. 21, 2025
Diabetic
neuropathy
is
a
consequence
of
long-term
hyperglycemia.
The
emergence
neuronal
condition
result
hyperglycemia-induced
oxidative
stress.
In
the
present
study,
streptozotocin-induced
diabetes
exhibited
notable
decrease
in
levels
phospholipids,
glycolipids,
gangliosides,
and
triglycerides
sciatic
nerve.
alterations
lipids
resulted
increase
cholesterol
to
phospholipid
ratio
nerve
diabetic
animals.
This
crucial
determines
rheological
properties
membranes
substantial
reduction
activity
membrane-bound
enzymes;
Ca2
+
ATPase
acetylcholinesterase.
Histological
examination
cross-section
mice
revealed
axonal
atrophy
disarrayed
myelin
sheath.
potential
therapeutic
impact
N-acetyl
Cysteine
(NAC),
powerful
antioxidant,
on
rat
model
was
evaluated.
NAC
administered
rats
drinking
water
for
period
8
weeks.
results
indicate
that
administration
restored
lipid
composition;
membrane
linked
enzymes,
improved
structural
defects
plays
protective
role
against
diabetes-induced
composition
leading
improvement
structure
function
membranes.
Overall,
findings
suggest
as
strategy
preventing
other
complications.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2062 - 2062
Published: Feb. 26, 2025
The
present
study
was
conducted
in
type
1
diabetic
(T1DM)
patients
to
evaluate
the
metabolic
and
glycemic
control
as
well
manifestations
of
neuropathy.
impact
continuous
glucose
monitoring
(CGM)
on
measured
parameters
also
analyzed.
A
total
61
T1DM
(age:
42.5
±
1.8
years,
DM
duration:
22.8
1.6
mean
SE)
participated
study.
In
total,
24
had
CGM
sensors
37
did
not.
Cardiovascular
autonomic
neuropathy
assessed
using
cardiovascular
reflex
tests.
Peripheral
sensory
function
evaluated
by
a
Neurometer
calibrated
tuning
fork
upper
lower
limbs.
Metabolic
status
characterized
determination
triglycerides,
high-density
lipoprotein
(HDL),
low-density
(LDL),
cholesterol,
glycated
haemoglobin
(HbA1c).
positive
correlation
found
between
HbA1c
triglyceride
levels
(r
=
0.28,
p
<
0.05).
users
non-users
differed
(0.9
0.1
vs.
1.24
0.12
mmol/L,
0.05),
HDL
cholesterol
(1.7
1.4
0.05
mmol/L),
(7.5
0.2
8.3
0.3%,
0.05)
well.
Significant
differences
were
for
Valsalva
ratio,
Neurometer,
results
non-users.
This
significant
T1DM.
use
resulted
improved
less
nerve
damage.
As
novel
finding,
is
presumed
prevent
both
micro-,
macrovascular
complications
and,
this
way,
potentially
reducing
mortality
rates.